Henderson Michael Thomas's Form 4 filing
Apogee Therapeutics, Inc. (APGE) · filed Jul 10, 2026
- Accession no.
- 0001104659-26-082758
- Filed
- Jul 10, 2026, 8:00 PM ET
- Trade date
- Jul 8-10, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $2.67M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henderson Michael ThomasCIK 0001779990 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | SSaleDisposed | −20,000 | $133.63 | −$2,672,600 | 995,987 | Direct | |
| Jul 10, 2026 | Common Stock | GGiftDisposed | −75,046 | $0.00 | $0 | 920,941 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.